Kubo T, Kajimoto T, Nohara T. Preventive of kidney stone containing flavonoid as active ingredient and production thereof: JP, 01305080 [P]. 1989-12-08.
[9]
Kubo T, Kajimoto T, Nohara T. Triterpenoidalsaponin, production thereof and preventive for renal litiasis containing above-mentioned saponin derivative as active ingredient: JP, 01301688 [P]. 1989-12-05.
[10]
Hirayama H, Wang Z, Nishi K, et al. Effect of Desmodium styracifolium-triterpenoid on calcium oxalate renal stones[J]. Br J Urol, 1993, 71: 143.
Yang X, Wang B C, Zhang X, et al. Evaluation of Lysimachia christinae Hance extracts as anticholecystitis and cholagogic agents in animals[J]. J Ethnopharmacol, 2011, 137(1): 57.
[23]
Zhao J, Davis L C, Verpoorte R. Elicitor signal transduction leading to production of plant secondary metabolites[J]. Biotechnol Adv, 2005, 23(4): 283.
[24]
Sabo A, Stilinovic N, Vukmirovic S, et al. Pharmacodynamic action of a commercial preparation of the mushroom Coprinus comatus in rats[J]. Phytother Res, 2010, 24(10): 1532.
[25]
Yeh T H, Krauland L, Singh V, et al. Liver-specific β-catenin knockout mice have bile canalicular abnormalities, bile secretory defect, and intrahepatic cholestasis[J]. Hepatology, 2010, 52(4): 1410.
Achiwa Yumiko. Inhibitory effects of plant constituents on the mutagenicity of C-nitro and C-nitroso compounds formed by reaction of sorbic acid with sodium nitrite[J].CA, 1996, 125: 141068.
Hayashi T, Sawa K, Kawasaki M, et al. Inhibition of cow\'s milk xanthine oxidase by flavonoids[J]. J Nat Prod, 1988, 51(5): 345.
[55]
Cos P, Ying L, Calomme M, et al. Structure-activity relationship and classification of flavonoids as inhibitors of xanthine oxidase and superoxide scavengers[J]. J Nat Prod, 1988, 61(1): 71.